Management of gout.
The diagnosis of gout depends on showing urate crystals in synovial effusions or, with less certainty, recognizing a characteristic clinical presentation. The management of gout has four phases: control of inflammation, diagnostic evaluation, education of the patient, and treatment for the hyperuricemia. Sound logical principles guide each aspect. Careful attention to these four phases of management should lead to highly satisfactory control of the syndrome of gout.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000493:Allopurinol / Q000627:therapeutic use; D003078:Colchicine / Q000627:therapeutic use; D005260:Female; D006073:Gout / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D010353:Patient Education as Topic; D010653:Phenylbutazone / Q000627:therapeutic use; D011339:Probenecid / Q000627:therapeutic use; D013442:Sulfinpyrazone / Q000627:therapeutic use; D014527:Uric Acid / Q000097:blood
D000305:Adrenal Cortex Hormones; D014527:Uric Acid; D000493:Allopurinol; D010653:Phenylbutazone; D011339:Probenecid; D003078:Colchicine; D013442:Sulfinpyrazone; D007213:Indomethacin